ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARP Annual Meeting 2019

Abstract Number: 89

Difference of Induced CD4+ and Natural Regulatory T Cells in Targeting Inflamed Synovial Tissues in Autoimmune Arthritis

Ximei Zhang1, Julie Wang 2, Nancy Olsen 3, Wael Jarjour 4 and Song Guo Zheng 4, 1Ohio State College of Medicine, Columbus, 2Ohio State University, columbus, 3Penn State University, Hershey, PA, 4Ohio State College of Medicine, Columbus, OH

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARP Annual Meeting 2019

Keywords: Animal models, inflammed synovial fibroblast, rheumatoid arthritis, Th17 cells and colitis, Treg cells

Session Information

Date: Sunday, November 10, 2019

Title: T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Enhanced evidence supports that autoimmune diseases often result from an imbalance between regulatory T cells (Tregs) and interleukin-17-producing T helper (Th17) cells. However, under inflammatory arthritic conditions, natural Treg cells (nTregs) lose Foxp3 expression and undergo transdifferentiation into Th17 cells, which has a key role in the pathogenesis of autoimmune arthritis. Our previous data showed that induced iTregs are able to alleviate collagen-induced arthritis(CIA), which inspired us to study the characteristics and functional difference between nTreg and iTreg especially their interaction with inflamed synovial fibroblast cells (ISFs), since ISFs are the most prominent player in both inflammation and joint destruction in rheumatoid arthritis.

Methods: To determine the stability of iTregs or nTregs in the present of ISFs isolated from CIA mice, iTregs or nTregs were co-cultured with ISFs and the expression of Foxp3 and IL-17a was detected by flow cytometry. We also pretreated nTreg and iTreg with ISFs and then compared their suppressive activities against effector T cells. Additionally, iTregs and nTregs were co-cultured with ISFs, and the production of the pro-inflammatory factors TNF-α, IL-6, IL-12, IL-18, IL-1β, IL-11, IL-15 , MCP-1, MMPs, as well as anti-inflammatory cytokines IL-10, IL-1R by ISFs were measured by qPCR, the tumor-like biologic behaviors of ISFs were detected by CCK-8 (proliferation) or crystal violet staining (migration and invasion). To determine the function of nTreg and iTregs on ISFs in CIA mice, ISFs isolated from CIA mice treated with nTregs or iTregs were also subjected to detect the expression of the pro-inflammatory factors and observe their tumor-like biologic behaviors. Finally, we also treated colitis mice with nTregs or iTregs that had been pretreated with or without ISFs to determine their difference in treating an inflammatory disease.

Results: iTregs are more stable functional in the presence of ISFs relative to nTregs. iTreg maintained most Foxp3 and less are converted into Th1 and/or Th17 cells when explored with ISFs. Moreover, ISFs treated with iTregs but not nTregs show reduced expression of pro-inflammatory factors and matrix metalloproteinases and suppressed tumor-like biologic behaviors, with lower proliferation, migration and invasion. In line with results in vitro, infusion of iTregs are more functional to reduce the activation of osteoclasts and bone erosion in CIA mice. ISFs isolated from CIA treated with iTregs also showed reduced expression of pro-inflammatory factors and matrix metalloproteinases and suppressed tumor-like biologic behaviors when compared to treated with nTregs. Adoptive transfer of iTregs that had been pretreated with ISFs are still able to alleviate colitis, while nTreg lost the therapeutic effects on colitis although they are effective if they are not pretreated with ISFs.

Conclusion: iTregs could be more stable and functional than nTregs in the environment of inflammatory synovial tissues in autimmune arthritis. The manipulation of iTreg therapy may provide an advantage strategy in treating patients with rheumatoid arthritis in the future.  


Disclosure: X. Zhang, None; J. Wang, None; N. Olsen, None; W. Jarjour, None; S. Zheng, None.

To cite this abstract in AMA style:

Zhang X, Wang J, Olsen N, Jarjour W, Zheng S. Difference of Induced CD4+ and Natural Regulatory T Cells in Targeting Inflamed Synovial Tissues in Autoimmune Arthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/difference-of-induced-cd4-and-natural-regulatory-t-cells-in-targeting-inflamed-synovial-tissues-in-autoimmune-arthritis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/difference-of-induced-cd4-and-natural-regulatory-t-cells-in-targeting-inflamed-synovial-tissues-in-autoimmune-arthritis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology